Dongli Yang - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Dongli Yang

Showing results (61-70 of 63) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 63 results.

Cancer Immunology, Immunotherapy : CII|March 24, 2026

A novel humanized immune stroma PDX cancer model for therapeutic studiesDongli Yang, Ian Beddows, Huijuan Tang, et al.

Cell Death & Disease|October 27, 2020

Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysisWei Gao, Yuliang Zhang, Hongjie Luo, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2018

Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1Wei Gao, Chunming Zhang, Wenqi Li, et al.

Pageof 7

Search research articles

Showing results (61-70 of 63) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 63 results.

Cancer Immunology, Immunotherapy : CII|March 24, 2026

A novel humanized immune stroma PDX cancer model for therapeutic studiesDongli Yang, Ian Beddows, Huijuan Tang, et al.

Cell Death & Disease|October 27, 2020

Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysisWei Gao, Yuliang Zhang, Hongjie Luo, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|October 21, 2018

Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1Wei Gao, Chunming Zhang, Wenqi Li, et al.

Pageof 7